-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EgKT9kljOxbt78nt8eFqSfnQ4QPL9AW6RSojANSTy8PB3K3oL9TIKaRdfD5dMdGY j7Sz4N8WrLwJLES1wIBaLg== 0001031927-10-000006.txt : 20100430 0001031927-10-000006.hdr.sgml : 20100430 20100430164221 ACCESSION NUMBER: 0001031927-10-000006 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091231 FILED AS OF DATE: 20100430 DATE AS OF CHANGE: 20100430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Witoshkin Walter W CENTRAL INDEX KEY: 0001297015 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23017 FILM NUMBER: 10788151 MAIL ADDRESS: STREET 1: 321 NORRISTOWN ROAD, SUITE 230 CITY: AMBLE STATE: PA ZIP: 19002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Echo Therapeutics, Inc. CENTRAL INDEX KEY: 0001031927 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411649949 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 FORGE PARKWAY CITY: FRANKLIN STATE: MA ZIP: 02038 BUSINESS PHONE: 508 553-8850 MAIL ADDRESS: STREET 1: 10 FORGE PARKWAY CITY: FRANKLIN STATE: MA ZIP: 02038 FORMER COMPANY: FORMER CONFORMED NAME: SONTRA MEDICAL CORP DATE OF NAME CHANGE: 20020702 FORMER COMPANY: FORMER CONFORMED NAME: CHOICETEL COMMUNICATIONS INC/MN/ DATE OF NAME CHANGE: 20020701 FORMER COMPANY: FORMER CONFORMED NAME: SONTRA MEDICAL CORP DATE OF NAME CHANGE: 20020701 5 1 primary_doc.xml PRIMARY DOCUMENT X0303 5 2009-12-31 0 0 1 0001031927 Echo Therapeutics, Inc. ECTE 0001297015 Witoshkin Walter W 321 NORRISTOWN ROAD, SUITE 230 AMBLE PA 19002 1 0 0 0 Common stock 2009-06-15 4 A 0 L 50000 0 A 444521 D Common stock 2009-08-18 4 A 0 L 25000 0 A 444521 D Non-qualified stock options 0.55 2009-02-20 4 A 0 L 50000 0.55 A 2019-02-20 Common stock 50000 444521 D One third of the options vested on February 20, 2010, one-third of the options will vest on February 20, 2011, and the remainder will vest on February 20, 2012. Includes 308,334 shares that may be acquired by Mr. Witoshkin within 60 days upon the exercise of stock options. The restricted shares shall vest upon the first to occur of (i) FDA approval of the Companys Symphony tCGM System; or (ii) the sale of all or substantially all of the assets of the Company or all or substantially all of the outstanding capital stock of the Company in exchange for liquid proceeds, which was defined as (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold upon on NYSE or NASDAQ upon termination of a lock-up period not to exceed one hundred eighty (180) days; or (d) or a combination of cash and the foregoing securities. Harry G. Mitchell, by power of attorney 2010-04-30 -----END PRIVACY-ENHANCED MESSAGE-----